Localization of multiple DNAzymes as a branchedzyme-powered nanodevice for the immunoassay of tumor biomarkers
Analytica Chimica Acta · 2023
DOI: 10.1016/j.aca.2023.341580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2023. Verfasst von Yanwen Jin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan Universtity, Chengdu, Sichuan, 610064, China. Hauptthemen laut MEDLINE: DNA, Catalytic, Metal Nanoparticles, Biosensing Techniques. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Sichuan Province Science and Technology Support Program, National Natural Science Foundation of China, Sichuan University.
Abstract (Originalsprache)
Traditional immunoassay methods often face challenges due to the labeling procedure of protein enzymes, the use of multiple antibodies, and severe conditions. To address these limitations, we propose the concept of incorporating branchedzyme-powered nanodevices into immunoassays. In this strategy, multiple DNAzymes are localized onto gold nanoparticles (AuNPs) along with substrates. The localization format facilitates intramolecular reactions between DNAzymes and substrates, leading to accelerated kinetics of the nanodevice. Upon the formation of an immunocomplex with an antibody on a 96-well plate, the branchedzyme-powered nanodevice catalytically releases multiple fluorescent signals under ambient temperature, eliminating the need for secondary antibodies. The branched DNAzymes exhibit catalytic properties similar to those of protein enzymes, thus simplifying the assay procedure and achieving isothermal detection. Furthermore, the detection process can be controlled by the addition or deletion of cofactors. Additionally, the affinity ligand can be easily modified to construct nanodevices specific to different targets without requiring extensive redesign. This strategy has demonstrated successful quantification of tumor biomarkers such as alpha-fetoprotein (AFP) and prostate-specific antigen (PSA) at subpicomolar concentrations, showcasing its suitability for clinical applications. Consequently, the branchedzyme-powered nanodevice represents a valuable addition to the immunoassay toolbox, opening new possibilities for clinical diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan Universtity, Chengdu, Sichuan, 610064, China.
- Department of Laboratory Medicine, West China Hospital, Sichuan Universtity, Chengdu, Sichuan, 610064, China.
- Analytical & Testing Centre, Sichuan University, Chengdu, Sichuan, 610064, China. Electronic address: junbochen@scu.edu.cn.
Förderung
- Sichuan Province Science and Technology Support Program
- National Natural Science Foundation of China
- Sichuan University
- Fundamental Research Funds for the Central Universities
- West China Hospital, Sichuan University
Zitieren
APA
Jin, Y., Huang, Z., Xu, B., & Chen, J. (2023). Localization of multiple DNAzymes as a branchedzyme-powered nanodevice for the immunoassay of tumor biomarkers. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2023.341580
Vancouver
Jin Y, Huang Z, Xu B, Chen J. Localization of multiple DNAzymes as a branchedzyme-powered nanodevice for the immunoassay of tumor biomarkers. Analytica Chimica Acta. 2023. doi:10.1016/j.aca.2023.341580
BibTeX
@article{Jin2023,
author = {Jin, Yanwen and Huang, Zhuochun and Xu, Bingyan and Chen, Junbo},
title = {Localization of multiple DNAzymes as a branchedzyme-powered nanodevice for the immunoassay of tumor biomarkers},
journal = {Analytica Chimica Acta},
year = {2023},
doi = {10.1016/j.aca.2023.341580}
}
EUVIMED